GSK PLC's ticker is and the CUSIP is 37733W204. A total of 858 filers reported holding GSK PLC in Q2 2024. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $506 | -10.3% | 13,160 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $564 | +16.8% | 13,160 | +0.8% | 0.00% | 0.0% |
| Q4 2023 | $483 | +58.4% | 13,050 | +54.8% | 0.00% | +50.0% |
| Q3 2023 | $305 | +2.0% | 8,430 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $299 | +17.7% | 8,410 | +17.6% | 0.00% | +100.0% |
| Q1 2023 | $254 | +16.5% | 7,150 | +14.8% | 0.00% | 0.0% |
| Q4 2022 | $218 | -99.9% | 6,230 | -33.2% | 0.00% | -50.0% |
| Q3 2022 | $274,000 | – | 9,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 13,993,208 | $497,808 | 52.84% |
| Eversept Partners, LP | 3,731,499 | $133,929,238 | 9.34% |
| Camber Capital Management LP | 4,600,000 | $163,668 | 5.03% |
| Callodine Capital Management, LP | 450,000 | $16,011,000 | 4.72% |
| EQUITY INVESTMENT CORP | 3,300,231 | $117,422,219 | 3.85% |
| Robinson Value Management, Ltd. | 128,939 | $4,587,650 | 3.52% |
| Hillman Capital Management, Inc. | 237,416 | $8,447,261 | 3.20% |
| Keystone Financial Planning, Inc. | 262,982 | $9,356,885 | 3.18% |
| Clean Yield Group | 198,160 | $7,050,533 | 3.00% |
| CLIFFORD CAPITAL PARTNERS LLC | 266,755 | $9,491,143 | 2.92% |